Humanity is aspiring to transcend old age and death. In the 21st century, this might no longer be an unattainable dream.
With everyday exposure to news media, movies, novels and theater, it is easy to assume that artificial intelligence (AI) will be able to provide all-powerful machinery capable of solving matters such as birth, aging, sickness or death — but how far has AI actually progressed in terms of medical science?
As top medical journals show, the progress made by AI goes no further than the ability to more meticulously analyze retinal changes as a result of diabetes in angiographic images; more precisely identify melanoma in dermoscopy images; find lymph node metastasis through analyzing histopathology images of breast cancer patients more accurately and faster than pathologists; forecast blood sugar levels by making calculations based on human genes and gastrointestinal microbiota; and assist oncologists’ decisionmaking by providing more informed and concise suggestions for cancer treatment, an AI technology provided by IBM’s Watson for Oncology.
The IBM Watson after its launch in 2016 received polarized opinions following its failure at the University of Texas’ MD Anderson Cancer Center, with some considering its AI capacity to be immature.
However, the higher the expectations, the greater the disappointment when the technology fails.
Just like the aforementioned advanced medical applications for AI technology, the IBM Watson for Oncology is by no means all-encompassing. It was not designed to diagnose cancers, but to target seven kinds of cancer and provide more in-depth and specific treatment advice. It also cannot give advice on surgery and radiation therapy, nor can it offer suggestions to patients with cancer recurrence or metastasis.
It might sound as if the IBM Watson is useless and not nearly as miraculous as the public believes it to be, but when it comes to treating people diagnosed with early stages of one of the seven targeted kinds of cancer, it provides detailed suggestions for medication and treatment, including chemotherapy, targeted therapy and immunotherapy.
Its suggestions are not only in accordance with the therapy already under way, but it also offers new directions and, in some cases, therapeutic opinions.
Within the scope of its database, IBM Watson is knowledgeable and it keeps “studying” new findings from journals to enhance the precision and subtlety of its analyses.
If the question is whether AI technology can replace an outstanding oncologist, the answer is “of course not.” However, if the question is changed to “Will AI under certain circumstances be able to assist oncologists by providing more precise therapeutic opinions for cancer patients?” then the answer is probably “yes.”
Every time a new technology emerges, public expectations rise too high on the assumption that it will solve all current difficulties. In particular, people find it hard to resist imaginative temptation when it comes to a sexy phrase such as “artificial intelligence.” These wild fantasies often lead to what is known as “technology hype.”
In terms of AI applications in medicine, moderate technology hype could encourage entrepreneurs to make venture investments and bring new capital into the field, thus encouraging the world’s top 10 companies to put a large amount of funds and talent into research. After all, finding the solution to issues related to birth, aging, sickness and death is humankind’s Holy Grail and a tremendously huge business that is growing 10 percent annually.
However, generating too much hype might lead to disappointments and the end of investment and research.
To AI researchers, this scenario sounds all too familiar. Since its emergence, AI has experienced at least two cold spells, both of which began when the technology was over-hyped and bestowed with too many unattainable goals. The Fifth-Generation Computer Systems initiated by Japan, for instance, disappeared quietly into thin air.
The question is whether there will be a third “cold spell” following the most recent emergence. Nevertheless, this possibility looks slim, as the causes of the two previous cold spells have been thoroughly analyzed and their lessons have been learned.
If concise development goals can be established, more rational expectations kept and an early harvest list for specific fields set up beforehand, current hardware processing speed and software maturity mean that the risk for a third cold spell is not great.
In other words, the public might finally be able to enjoy the fruits of AI technology.
Jack Li is dean of Taipei Medical University’s College of Medical Science and founder of the Center for Artificial Intelligence for Medical and Health Innovation.
Translated by Chang Ho-ming
Minister of Labor Hung Sun-han (洪申翰) on April 9 said that the first group of Indian workers could arrive as early as this year as part of a memorandum of understanding (MOU) between the Taipei Economic and Cultural Center in India and the India Taipei Association. Signed in February 2024, the MOU stipulates that Taipei would decide the number of migrant workers and which industries would employ them, while New Delhi would manage recruitment and training. Employment would be governed by the laws of both countries. Months after its signing, the two sides agreed that 1,000 migrant workers from India would
In recent weeks, Taiwan has witnessed a surge of public anxiety over the possible introduction of Indian migrant workers. What began as a policy signal from the Ministry of Labor quickly escalated into a broader controversy. Petitions gathered thousands of signatures within days, political figures issued strong warnings, and social media became saturated with concerns about public safety and social stability. At first glance, this appears to be a straightforward policy question: Should Taiwan introduce Indian migrant workers or not? However, this framing is misleading. The current debate is not fundamentally about India. It is about Taiwan’s labor system, its
On March 31, the South Korean Ministry of Foreign Affairs released declassified diplomatic records from 1995 that drew wide domestic media attention. One revelation stood out: North Korea had once raised the possibility of diplomatic relations with Taiwan. In a meeting with visiting Chinese officials in May 1995, as then-Chinese president Jiang Zemin (江澤民) prepared for a visit to South Korea, North Korean officials objected to Beijing’s growing ties with Seoul and raised Taiwan directly. According to the newly released records, North Korean officials asked why Pyongyang should refrain from developing relations with Taiwan while China and South Korea were expanding high-level
Japan’s imminent easing of arms export rules has sparked strong interest from Warsaw to Manila, Reuters reporting found, as US President Donald Trump wavers on security commitments to allies, and the wars in Iran and Ukraine strain US weapons supplies. Japanese Prime Minister Sanae Takaichi’s ruling party approved the changes this week as she tries to invigorate the pacifist country’s military industrial base. Her government would formally adopt the new rules as soon as this month, three Japanese government officials told Reuters. Despite largely isolating itself from global arms markets since World War II, Japan spends enough on its own
RSS